日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B

标准半衰期和延长半衰期因子替代产品治疗A型和B型血友病的真实世界疗效

期刊:Blood Coagulation & Fibrinolysis
影响因子:1.1
doi:10.1097/MBC.0000000000000885
Chhabra, Amit; Spurden, Dean; Fogarty, Patrick F; Tortella, Bartholomew J; Rubinstein, Emily; Harris, Simon; Pleil, Andreas M; Mellor, Jennifer; de Courcy, Jonathan; Alvir, José
发表日期：2020
文献求助 收藏

Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment

尽管持续治疗，但类风湿性关节炎控制不佳患者的临床特征和患者报告结局

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2017-000615
Taylor, Peter C; Alten, Rieke; Gomez-Reino, Juan J; Caporali, Roberto; Bertin, Philippe; Sullivan, Emma; Wood, Robert; Piercy, James; Vasilescu, Radu; Spurden, Dean; Alvir, Jose; Tarallo, Miriam
关节炎
发表日期：2018
文献求助 收藏

Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice

影响当前欧洲风湿病学实践中生物疗法使用和达标治疗建议采纳的因素

期刊:Patient Preference and Adherence
影响因子:2
doi:10.2147/PPA.S170054
Taylor, Peter C; Alten, Rieke; Reino, Juan J Gomez; Caporali, Roberto; Bertin, Philippe; Sullivan, Emma; Wood, Robert; Piercy, James; Vasilescu, Radu; Spurden, Dean; Alvir, Jose; Tarallo, Miriam
发表日期：2018
文献求助 收藏

Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products

对接受标准半衰期与延长半衰期凝血因子IX产品治疗的B型血友病患者以及从标准半衰期产品转换为延长半衰期产品的患者的凝血因子IX使用量（IU）和相关支出进行真实世界分析

期刊:
影响因子:
doi:10.18553/jmcp.2018.17212
Tortella, Bartholomew J; Alvir, José; McDonald, Margaret; Spurden, Dean; Fogarty, Patrick F; Chhabra, Amit; Pleil, Andreas M
发表日期：2018
文献求助 收藏

Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis

系统评价、网络荟萃分析和经济学评价生物疗法治疗活动性银屑病关节炎

期刊:BMC Musculoskeletal Disorders
影响因子:2.4
doi:10.1186/1471-2474-15-26
Cawson, Matthew Richard; Mitchell, Stephen Andrew; Knight, Chris; Wildey, Henry; Spurden, Dean; Bird, Alex; Orme, Michelle Elaine
关节炎
银屑病
发表日期：2014
文献求助 收藏

Long-Term Drug Survival of TNF Inhibitor Therapy in RA Patients: A Systematic Review of European National Drug Registers

TNF抑制剂治疗类风湿关节炎患者的长期药物生存率：欧洲国家药品注册系统的回顾

期刊:International Journal of Rheumatology
影响因子:2.3
doi:10.1155/2013/764518
Arora, Anamika; Mahajan, Anadi; Spurden, Dean; Boyd, Helen; Porter, Duncan
关节炎
发表日期：2013
文献求助 收藏

Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70

对既往接受过改善病情抗风湿药物治疗的类风湿关节炎患者进行联合治疗和单药治疗的系统评价和网络荟萃分析：分析美国风湿病学会标准评分20、50和70

期刊:Biologics-Targets & Therapy
影响因子:3.4
doi:10.2147/BTT.S36707
Orme, Michelle E; Macgilchrist, Katherine S; Mitchell, Stephen; Spurden, Dean; Bird, Alex
关节炎
发表日期：2012
文献求助 收藏